UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 5.802

Sortiert nach

Linarin enhances melanogenesis in B16F10 cells via MAPK and PI3K/AKT signaling pathways

Journal of Applied Biological Chemistry, 2021, 64(4), , pp.447-451

2021

Volltextzugriff (PDF)

Linarin enhances melanogenesis in B16F10 cells via MAPK and PI3K/AKT signaling pathways

Journal of applied biological chemistry, 2021-12, Vol.64 (4), p.447-451

2021

Volltextzugriff (PDF)

Chrysoeriol Enhances Melanogenesis in B16F10 Cells Through the Modulation of the MAPK, AKT, PKA, and Wnt/β-Catenin Signaling Pathways

Natural product communications, 2022-01, Vol.17 (1), p.1934578

2022

Volltextzugriff (PDF)

Anti-photoaging Constituents from Eurya emarginata Leaves

Journal of the Korean Chemical Society, 2023-04, Vol.67 (2), p.150-155

2023

Volltextzugriff (PDF)

Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211042812-17588359211042812

2021

Volltextzugriff (PDF)

Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics

Journal of Korean medical science, 2022-06, p.1-11

2022

Volltextzugriff (PDF)

Phase II study about efficacy and safety of the continuous intravenous infusion of ketamine as adjuvant to opioids in terminally ill cancer patients with refractory cancer pain

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24139-e24139

2023

Volltextzugriff (PDF)

GNI Corpus Version 1.0: Annotated Full-Text Corpus of Genomics & Informatics to Support Biomedical Information Extraction

Genomics & informatics, 2018, Vol.16 (3), p.75-77

2018

Volltextzugriff (PDF)

Association of ascitic neutrophil to lymphocyte ratio with prognosis in patients with advanced gastric cancer

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.443-443

2020

Volltextzugriff (PDF)

Analysis of prescription pattern of the fentanyl citrate sublingual tablets according to liver or kidney function abnormality of cancer patients

Journal of clinical oncology, 2018, Vol.36 (34_suppl), p.119-119

2018

Volltextzugriff (PDF)

Fully Automated Continuous Centrifugal Microfluidics Isolates Natural Killer Cells with High Performance and Minimal Stress

Analytical chemistry (Washington), 2023-07, Vol.95 (26), p.9949-9958

2023

Volltextzugriff (PDF)

Real-world safety and effectiveness of CT-P6 (biosimilar trastuzumab): A post-marketing surveillance study in Korea

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13025-e13025

2023

Volltextzugriff (PDF)

Abstract P5-16-03: Phase II study of trastuzumab biosimilar (Herzuma®) plus gedatolisib in patients with HER-2 positive metastatic breast cancer who progressed after 2 or more HER-2 directed chemotherapy (BR 18-13, KM-10A): Interim analysis

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P5-P5-16-03

2022

Volltextzugriff (PDF)

Phase II study of trastuzumab-pkrb and docetaxel anhydrous combination therapy in recurrent or metastatic salivary ductal carcinomas (KCSG HN18-08/KM11)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.6018-6018

2022

Volltextzugriff (PDF)

Real-world outcomes of second-line ramucirumab plus paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma: A nationwide retrospective study in Korea (KCSG-ST19-16)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4056-4056

2021

Volltextzugriff (PDF)

A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas

Cancer, 2023-10, Vol.129 (19), p.2966-2974

2023

Volltextzugriff (PDF)

Validity and reliability of Korean version of simplified nutritional appetite questionnaire in patients with advanced cancer: A multicenter, longitudinal study

Journal of clinical oncology, 2017-11, Vol.35 (31_suppl), p.211-211

2017

Volltextzugriff (PDF)

Abstract PS11-39: Phase II pilot study of trastuzumab biosimilar (herzuma®) plus gedatolisib in patients with HER-2 positive metastatic breast cancer who progressed after 2 or more HER-2 directed chemotherapy [KM-10A/KCSG18-13 interim analysis]

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS11-39-PS11-39

2021

Volltextzugriff (PDF)

A Phase II Study About Efficacy and Safety of the Continuous IntraVenous Infusion of Ketamine as Adjuvant to Opioids in Terminally Ill Cancer Patients With Refractory Cancer Pain (CIVIK Trial)

American journal of hospice & palliative medicine, 2024-05, p.10499091241252977-10499091241252977

2024

Volltextzugriff (PDF)

Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation

Theranostics, 2022-01, Vol.12 (8), p.3676-3689

2022

Volltextzugriff (PDF)

A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy

Cancer Research and Treatment, 2023, 55(4), , pp.1096-1103

2023

Volltextzugriff (PDF)

Protective effects of quercetin-3-glucosyl-(1-2)-rhamnoside from Schizophragma hydrangeoides leaves on ultraviolet A-induced photoaging in human dermal fibroblasts

Journal of applied biological chemistry, 2022-12, Vol.65 (4), p.277-286

2022

Volltextzugriff (PDF)

Role of D-dimer in advanced cancer patients receiving end of life care

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e20504-e20504

2014

Volltextzugriff (PDF)

PP213 Three-year follow-up of the ATTRACTION-4 Korean subgroup analysis: First-line (1L) nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with previously untreated, advanced, or recurrent gastric/gastro-esophageal junction (G/GEJ) cancer

ESMO open, 2023-12, Vol.8 (1), p.102169, Article 102169

2023

Volltextzugriff (PDF)

Pilot trial of epidermal growth factor (EGF) ointment for the patients with epidermal growth factor receptor (EGFR) inhibitor related skin side effects

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.10054-10054

2018

Volltextzugriff (PDF)

1 – 25 von 5.802

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.930)
Mit Volltextzugriff
(5.600)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.517)
Life Sciences & Biomedicine
(1.434)
Technology
(782)
Physical Sciences
(690)
Chemistry
(455)
Materials Science
(452)
Materials Science, Multidisciplinary
(346)
Engineering
(320)
Original
(311)
Physics
(285)
Science & Technology - Other Topics
(267)
Cardiovascular
(230)
Physics, Applied
(216)
Chemistry, Multidisciplinary
(212)
Chemistry, Physical
(172)
Cardiology
(157)
Internal Medicine
(152)
Nanoscience & Nanotechnology
(150)
Engineering, Electrical & Electronic
(143)
Patients
(134)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Linarin enhances melanogenesis in B16F10 cells via MAPK and PI3K/AKT signaling pathways

Linarin enhances melanogenesis in B16F10 cells via MAPK and PI3K/AKT signaling pathways

Chrysoeriol Enhances Melanogenesis in B16F10 Cells Through the Modulation of the MAPK, AKT, PKA, and Wnt/β-Catenin Signaling Pathways

Anti-photoaging Constituents from Eurya emarginata Leaves

Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)

Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics

Phase II study about efficacy and safety of the continuous intravenous infusion of ketamine as adjuvant to opioids in terminally ill cancer patients with refractory cancer pain

GNI Corpus Version 1.0: Annotated Full-Text Corpus of Genomics & Informatics to Support Biomedical Information Extraction

Association of ascitic neutrophil to lymphocyte ratio with prognosis in patients with advanced gastric cancer

Analysis of prescription pattern of the fentanyl citrate sublingual tablets according to liver or kidney function abnormality of cancer patients

Fully Automated Continuous Centrifugal Microfluidics Isolates Natural Killer Cells with High Performance and Minimal Stress

Real-world safety and effectiveness of CT-P6 (biosimilar trastuzumab): A post-marketing surveillance study in Korea

Abstract P5-16-03: Phase II study of trastuzumab biosimilar (Herzuma®) plus gedatolisib in patients with HER-2 positive metastatic breast cancer who progressed after 2 or more HER-2 directed chemotherapy (BR 18-13, KM-10A): Interim analysis

Phase II study of trastuzumab-pkrb and docetaxel anhydrous combination therapy in recurrent or metastatic salivary ductal carcinomas (KCSG HN18-08/KM11)

Real-world outcomes of second-line ramucirumab plus paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma: A nationwide retrospective study in Korea (KCSG-ST19-16)

A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas

Validity and reliability of Korean version of simplified nutritional appetite questionnaire in patients with advanced cancer: A multicenter, longitudinal study

Abstract PS11-39: Phase II pilot study of trastuzumab biosimilar (herzuma®) plus gedatolisib in patients with HER-2 positive metastatic breast cancer who progressed after 2 or more HER-2 directed chemotherapy [KM-10A/KCSG18-13 interim analysis]

A Phase II Study About Efficacy and Safety of the Continuous IntraVenous Infusion of Ketamine as Adjuvant to Opioids in Terminally Ill Cancer Patients With Refractory Cancer Pain (CIVIK Trial)

Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation

A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy

Protective effects of quercetin-3-glucosyl-(1-2)-rhamnoside from Schizophragma hydrangeoides leaves on ultraviolet A-induced photoaging in human dermal fibroblasts

Role of D-dimer in advanced cancer patients receiving end of life care

PP213 Three-year follow-up of the ATTRACTION-4 Korean subgroup analysis: First-line (1L) nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with previously untreated, advanced, or recurrent gastric/gastro-esophageal junction (G/GEJ) cancer

Pilot trial of epidermal growth factor (EGF) ointment for the patients with epidermal growth factor receptor (EGFR) inhibitor related skin side effects

Aktive Filter

Suchergebnisse filtern